{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:35:28Z","timestamp":1787312128866,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jash.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T23:59:43Z","timestamp":1470355183000},"page":"755-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension"],"prefix":"10.1016","volume":"10","author":[{"given":"Stuart","family":"Isaacson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vernino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Rowse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwa","family":"Kalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jash.2016.07.010_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.jash.2016.07.010_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.108.805887","article-title":"Neurogenic orthostatic hypotension: a pathophysiological approach","volume":"119","author":"Goldstein","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jash.2016.07.010_bib3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","article-title":"Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management","volume":"260","author":"Metzler","year":"2013","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.jash.2016.07.010_bib4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/HJH.0000000000000235","article-title":"Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis","volume":"32","author":"Angelousi","year":"2014","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.jash.2016.07.010_bib5","first-page":"101","article-title":"Mortality and prognosis in patients with neurogenic orthostatic hypotension","volume":"27","author":"Maule","year":"2012","journal-title":"Funct Neurol"},{"key":"10.1016\/j.jash.2016.07.010_bib6","series-title":"Full prescribing information","year":"2014"},{"issue":"1","key":"10.1016\/j.jash.2016.07.010_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.jash.2016.07.010_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (NOH306B)","volume":"30","author":"Hauser","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jash.2016.07.010_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jash.2016.07.010_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","article-title":"Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)","volume":"4","author":"Hauser","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jash.2016.07.010_bib11","first-page":"S424","article-title":"Durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)","volume":"27","author":"Isaacson","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.jash.2016.07.010_bib12","first-page":"S93","article-title":"Durability of effect with long-term droxidopa treatment in patients with symptomatic NOH","volume":"30","author":"Isaacson","year":"2015","journal-title":"Mov Disord"},{"issue":"9205","key":"10.1016\/j.jash.2016.07.010_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","article-title":"Hypertensive cardiovascular damage in patients with primary autonomic failure","volume":"355","author":"Vagaonescu","year":"2000","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jash.2016.07.010_bib14","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/01.CIR.101.23.2710","article-title":"Sympathetically mediated hypertension in autonomic failure","volume":"101","author":"Shannon","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jash.2016.07.010_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1538-7836.2008.02835.x","article-title":"Open-label trials and drug registration: a European regulator's view","volume":"6","author":"Casteels","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.jash.2016.07.010_bib16","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1538-7836.2011.04507.x","article-title":"External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?","volume":"9","author":"Beyer-Westendorf","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jash.2016.07.010_bib17","series-title":"Northera\u2122 (Droxidopa) Advisory Committee Briefing Document","year":"2014"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317111630451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317111630451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T16:05:57Z","timestamp":1600963557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193317111630451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S193317111630451X"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2016.07.010","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author. Published by Elsevier Inc. on behalf of American Society of Hypertension.","name":"copyright","label":"Copyright"}]}}